Navigation Links
First Choice Rehabilitation Specialists Joins Select Medical
Date:1/19/2012

MECHANICSBURG, Pa., Jan. 18, 2012 /PRNewswire/ -- Select Medical announced it has become the majority owner of First Choice Rehabilitation Specialists, a well-known provider of physical therapy in the greater Harrisburg area. First Choice's 13 clinics join the Select Medical family with a 25-year reputation for providing high-quality rehabilitation in outpatient settings.

Together, First Choice and another Select Medical brand known as Select Physical Therapy will offer physical therapy and related services at 18 convenient locations in Harrisburg, Mechanicsburg, Carlisle, Lebanon, Upper Dauphin County and Perry County.  

"Patients and referral sources alike will benefit from this new partnership between two trusted names in physical therapy," said Michael Collins, P.T, ATC, MBA, a regional director for Select Medical's outpatient division.

"We are excited about this opportunity because we share similar cultures and philosophies regarding patient care," said Ken Lennington, P.T., a co-owner of First Choice Rehabilitation Specialists. "I believe a combined Select Physical Therapy and First Choice will strengthen our leadership position in the local health care community. Together, we intend to remain focused on how we can help each other and our community have easier access to the best available treatments."

Nationally, Select Medical is the industry leader in providing physical and hand therapy services. It also owns or operates well-known providers such as Baylor Institute for Rehabilitation Centers, Kessler Rehabilitation Centers, Kentucky Orthopedic Rehabilitation Team (KORT), and NovaCare Rehabilitation. All combined, Select Medical's national outpatient network includes more than 950 outpatient centers in 34 states and the District of Columbia. Its centers all conform to similar standards of excellence in providing preventative and rehabilitative services that maximize function and physical well-being for patien
'/>"/>

SOURCE Select Medical
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Pacific Meso Center Receives Generous Donation to First Free-Standing Mesothelioma Research Laboratory in Los Angeles
2. First Free-Standing International Mesothelioma Research Laboratory Opens in Los Angeles
3. Varian Medical Systems Schedules First Quarter FY2012 News Release and Conference Call
4. Amgen Announces 2012 First Quarter Dividend
5. Eye Surgery Center of Michigan First in Southeast Michigan to Perform Bladeless Cataract Surgery Using New LenSx® Laser Technology
6. The Pharmabiotic Research Institute (PRI) is Preparing to Publish its First Works on the Therapeutic and Medicinal Potential of Probiotics
7. Tiger Woods Gives Exclusive First Interview Since POWERED by FUSE Announcement!
8. China Cord Blood Corporation to Report Second Quarter and First Half of Fiscal 2012 Financial Results
9. Webcor Builders Selected as the General Contractor for First Phase of LA BioMeds New Campus Master Plan
10. Fitzsimons Redevelopment Authority Rolls Out First Phase of Strategic Refocus With Appointment of Four Key Leaders in The Bioscience Industry to Its Board of Directors
11. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... DUBLIN , Sept. 18, 2014 ... the "Global and Chinese Stem Cell Industry Report, ... Stem cells are undifferentiated biological cells that can differentiate ... produce more stem cells. Stem cell therapy can be ... of hematological system disease), nervous system diseases, damage or ...
(Date:9/18/2014)... Research and Markets has announced ... Report 2014" report to their offering. ... a professional and in-depth study on the current state ... report provides a basic overview of the industry including ... albumin market analysis is provided for the international markets ...
(Date:9/18/2014)... 18, 2014 Leatherwood Plastics has ... material, to stay competitive in the semiconductor, clean ... materials ultimately impact product quality and productivity, according ... , Established in 1980 in Lewisville, TX, ... fabricators have left the business. Much of Leatherwood’s ...
(Date:9/18/2014)...  MEI Pharma, Inc. (Nasdaq: MEIP ), an ... for cancer, announced today that Daniel P. Gold , ... NewsMakers in the Biotech Industry conference on Friday, ... Millennium Broadway Hotel & Conference Center in New ... be accessed at www.meipharma.com . A replay will be ...
Breaking Biology Technology:Global and Chinese Stem Cell Industry Report, 2014-2017 2Global and Chinese Stem Cell Industry Report, 2014-2017 3Global Human Albumin Industry Report 2014 2Global Human Albumin Industry Report 2014 3Leatherwood Plastics Selects Vycom’s Flametec PVC-C Material to Stay Competitive in Semiconductor and Lab Equipment Industries 2MEI Pharma To Present At BioCentury's NewsMakers Conference 2MEI Pharma To Present At BioCentury's NewsMakers Conference 3
... Close Completes $35 Million Financing, WOBURN, Mass., Nov. ... generation biologics for the treatment and,prevention of cancer and ... financing, concurrent with the completion of a,venture debt transaction, ... intends to use the capital to complete its preparations ...
... for,U-Md. Bioscience Day, COLLEGE PARK, Md., Nov. 14 ... technology enabling him to develop an,infinite variety of safe, ... capitalists and the title of "Best Inventor Pitch" at ... university,s Office of Technology Commercialization,the College of Chemical and ...
... Inc. (Nasdaq: ADLS ), a biopharmaceutical company ... drugs in the,therapeutic areas of infection, cancer and ... third quarter ended September 30,2007. (Logo: ... three months ended September 30, 2007 was $5.8,million ...
Cached Biology Technology:BioVex Closes Second Round of Series E Financing 2Pure Plastics Pitch Proves Perfect 2Pure Plastics Pitch Proves Perfect 3Advanced Life Sciences Announces Third Quarter 2007 Financial Results 2Advanced Life Sciences Announces Third Quarter 2007 Financial Results 3Advanced Life Sciences Announces Third Quarter 2007 Financial Results 4Advanced Life Sciences Announces Third Quarter 2007 Financial Results 5Advanced Life Sciences Announces Third Quarter 2007 Financial Results 6Advanced Life Sciences Announces Third Quarter 2007 Financial Results 7Advanced Life Sciences Announces Third Quarter 2007 Financial Results 8Advanced Life Sciences Announces Third Quarter 2007 Financial Results 9
(Date:9/18/2014)... "frequent flyers" program, fruit flies surely would be eligible ... increasing numbers of fruit fly research studies. One fruit ... and another is scheduled launch to the station Sept. ... December. , Fruit flies are biomedical research models studied ... organisms can reveal the basis for health and disease ...
(Date:9/18/2014)... in DNA, tiny strands of nucleic acid that contain ... this genetic data, our DNA is copied into RNA ... perform tasks in our cells. , Several years ... Unlike all other known RNAs, this molecule is circular, ... abundant, little has been known about how they are ...
(Date:9/18/2014)... so you might expect that most would have an ... dogs are distinctly more pessimistic than others, research from ... is exciting because it measures positive and negative emotional ... and dog owners an insight into the outlook of ... from the Faculty of Veterinary Science. Her PhD research ...
Breaking Biology News(10 mins):Buzzing with activity: Fruit flies orbit Earth for science 2Buzzing with activity: Fruit flies orbit Earth for science 3Buzzing with activity: Fruit flies orbit Earth for science 4Scientists find how mysterious 'circular RNA' is formed, claim muscular dystrophy link 2Dogs can be pessimists too 2Dogs can be pessimists too 3
... from the University of Calgary,s Faculty of Medicine shows ... iPhone application with the same accuracy as a diagnosis ... particularly useful in rural medical settings. This allows for ... where the physicians and patients are located. Neuro-radiologists ...
... TAIPEI, May 9, 2011 /PRNewswire-Asia/ -- PharmaEngine, Inc. and ... agreement under which PharmaEngine grants back to Merrimack the ... the designation of MM-398 by Merrimack) in Asia and ... Under the agreement, PharmaEngine will receive an upfront payment ...
... seeking to understand molecular mechanisms underlying various diseases, notably ... tissues specimen of patients for the expression status of ... expression status of each gene in the genome, measured ... expression profile. Since each of the tens of thousands ...
Cached Biology News:iPhone can diagnose stroke: study 2PharmaEngine, Inc. and Merrimack Pharmaceuticals, Inc. Enter into a Licensing and Collaboration Agreement on PEP02 (MM-398), Nanoliposomal Irinotecan 2Medusa-structure of gene regulatory network: Dominance of transcription factors in cancer subtypes 2Medusa-structure of gene regulatory network: Dominance of transcription factors in cancer subtypes 3Medusa-structure of gene regulatory network: Dominance of transcription factors in cancer subtypes 4
Human DEP-1/CD148 Fluorescein MAb (Clone 143-41) Protein Family: Granulocyte Markers, Monocyte Markers, Phosphatases & Regulators, Other Dendritic Cell Molecules...
An excellent carbonyl-reactive FRET quencher paired with Trp or Tyr. Minimum Purity: 95%. Abs(max): ~350 nm; Em(max): none. Solvent System:DMSO or DMF....
...
...
Biology Products: